{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Gly",
          "alt": "Ser",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the LRRK2 gene cause late-onset Parkinsonâ€™s disease (PD). The study suggests that over-activation of LRRK2 predisposes humans to develop PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to LRRK2's kinase activity and its impact on PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study employed a KESTREL screen and various kinase assays to assess the activity of LRRK2 and its mutants.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are a standard method for evaluating the activity of kinase proteins, which is directly related to the disease mechanism of PD as defined by LRRK2 activity.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of multiple assays, including autophosphorylation, phosphorylation of MBP, moesin, and a peptide substrate (LRRKtide), which are all relevant to assessing kinase activity. The assays were performed under controlled conditions with appropriate substrates and mutants as controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The study presents mean specific activities and standard deviations for assays carried out in triplicate, indicating the use of statistical analyses.",
            "judgment": "Yes",
            "reasoning": "The paper provides quantitative data and statistical measures for the functional assays, allowing for the estimation of the effect of the G2019S mutation on LRRK2 activity."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While the paper provides statistical data, it does not directly calculate OddsPath, which would require a more detailed statistical analysis beyond the scope of this study."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "No",
            "reasoning": "As no direct OddsPath calculation was performed, the strength cannot be inferred from this step. However, the increase in Vmax suggests a significant effect on kinase activity."
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G2019S mutation in LRRK2 significantly enhances kinase activity, as demonstrated through various functional assays, including autophosphorylation and phosphorylation of specific substrates. The increase in Vmax and the consistent enhancement of activity across different assays suggest a very strong pathogenic evidence for this variant."
    }
  ]
}